Skip to main content
. 2021 May 26;12:676619. doi: 10.3389/fimmu.2021.676619

Figure 4.

Figure 4

BAFF enhances B cell subset shift, but not IL-10 production, in treated patients. Association of treatment status (UNT = untreated, visualized in white; IFNB = interferon-β, visualized in dark grey) and stimulation condition (medium, BAFF, CpG or BAFF + CpG) with (A) B cells (NMedium= 6 UNT, 6 IFNB; NBAFF= 6 UNT, 6 IFNB; NCpG= 6 UNT, 6 IFNB; NCpG+BAFF= 6 UNT, 6 IFNB), (B) transitional B cells (NMedium= 6 UNT, 6 IFNB; NBAFF= 6 UNT, 6 IFNB; NCpG= 6 UNT, 6 IFNB; NCpG+BAFF= 6UNT, 5 IFNB), (C) naïve B cells (NMedium= 6 UNT, 6 IFNB; NBAFF= 6 UNT, 6 IFNB; NCpG= 6 UNT, 6 IFNB; NCpG+BAFF= 6 UNT, 5 IFNB), (D) memory CD27+ B cells (NMedium= 6 UNT, 6 IFNB; NBAFF= 6 UNT, 6 IFNB; NCpG= 6 UNT, 6 IFNB; NCpG+BAFF= 6 UNT, 5 IFNB), (E) IL10+ B cells (NMedium= 6 UNT, 6 IFNB; NBAFF= 6 UNT, 6 IFNB; NCpG= 6 UNT, 6 IFNB; NCpG+BAFF= 6 UNT, 5 IFNB), (F) IL10+ transitional B cells (NMedium= 6 UNT, 6 IFNB; NBAFF= 6 UNT, 6 IFNB; NCpG= 6 UNT, 6 IFNB; NCpG+BAFF= 6 UNT, 5 IFNB), (G) IL10+ naïve B cells (NMedium= 6 UNT, 6 IFNB; NBAFF= 6 UNT, 6 IFNB; NCpG= 6 UNT, 6 IFNB; NCpG+BAFF= 6 UNT, 5 IFNB) and (H) IL10+ memory CD27+ B cells (NMedium= 6 UNT, 6 IFNB; NBAFF= 6 UNT, 6 IFNB; NCpG= 6 UNT, 6 IFNB; NCpG+BAFF= 6 UNT, 5 IFNB). To test for differences between untreated and IFNB treated patients, we used a Wilcoxon test. To test for differences between medium and other stimulation conditions or CpG and CpG + BAFF within the IFNB treated and untreated patients, we used a Sign-test. P values ≤ 0.05 are depicted. Box-whisker plots represent median, quartiles and 1.5 x IQR.